Bola Tayo

1.1k total citations · 1 hit paper
12 papers, 750 citations indexed

About

Bola Tayo is a scholar working on Pharmacology, Psychiatry and Mental health and Oncology. According to data from OpenAlex, Bola Tayo has authored 12 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 5 papers in Psychiatry and Mental health and 3 papers in Oncology. Recurrent topics in Bola Tayo's work include Cannabis and Cannabinoid Research (9 papers), Bipolar Disorder and Treatment (4 papers) and Diet, Metabolism, and Disease (3 papers). Bola Tayo is often cited by papers focused on Cannabis and Cannabinoid Research (9 papers), Bipolar Disorder and Treatment (4 papers) and Diet, Metabolism, and Disease (3 papers). Bola Tayo collaborates with scholars based in United Kingdom, United States and Sweden. Bola Tayo's co-authors include Gilmour Morrison, Lesley Taylor, Barry E. Gidal, Graham Blakey, Julie C. Crockett, David Critchley, Daniel Checketts, Joris Berwaerts, Farhad Sahebkar and Michael Sabel and has published in prestigious journals such as British Journal of Cancer, The American Journal of Gastroenterology and Epilepsia.

In The Last Decade

Bola Tayo

12 papers receiving 744 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects

2018 341 citations Lesley Taylor, Barry E. Gidal et al. CNS Drugs profile →

Peers

Countries citing papers authored by Bola Tayo

Since Specialization

Citations

This map shows the geographic impact of Bola Tayo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bola Tayo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bola Tayo more than expected).

Fields of papers citing papers by Bola Tayo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bola Tayo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bola Tayo. The network helps show where Bola Tayo may publish in the future.

Co-authorship network of co-authors of Bola Tayo

This figure shows the co-authorship network connecting the top 25 collaborators of Bola Tayo. A scholar is included among the top collaborators of Bola Tayo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bola Tayo. Bola Tayo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Pharmacokinetic Drug‐Drug Interaction With Coadministration of Cannabidiol and Everolimus in a Phase 1 Healthy Volunteer Trial 2023 ·Clinical Pharmacology in Drug Development ·(unknown), Joris Berwaerts, David Critchley, (unknown), Cuiping Chen, (unknown), Bola Tayo	12
2	A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma 2021 ·British Journal of Cancer ·(unknown), Chris Twelves, Michael Sabel, Daniel Checketts, Sharon A. Miller, Bola Tayo, Maria Jové, Lucy Brazil, Susan Short	78
3	A Phase 1 Open‐Label, Fixed‐Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects 2021 ·Clinical Pharmacology in Drug Development ·(unknown), Bola Tayo, David Critchley	21
4	A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug–Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy 2020 ·CNS Drugs ·Elinor Ben‐Menachem, Boudewijn Gunning, Carmen Cabrera, Kevan VanLandingham, Julie C. Crockett, David Critchley, (unknown), Bola Tayo, Gilmour Morrison, Manuel Toledo	37
5	Abrupt withdrawal of cannabidiol (CBD): A randomized trial 2020 ·Epilepsy & Behavior ·Lesley Taylor, Julie C. Crockett, Bola Tayo, Daniel Checketts, Kenneth W. Sommerville	37
6	Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial 2020 ·Developmental Medicine & Child Neurology ·Charlie Fairhurst, Ram Kumar, Daniel Checketts, Bola Tayo, (unknown)	22
7	A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects 2020 ·Epilepsia ·Julie C. Crockett, David Critchley, Bola Tayo, Joris Berwaerts, Gilmour Morrison	59
8	A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment 2019 ·Clinical Pharmacokinetics ·Bola Tayo, Lesley Taylor, Farhad Sahebkar, Gilmour Morrison	46
9	Novel 1 L polyethylene glycol-based bowel preparation (NER1006): proof of concept assessment versus standard 2 L polyethylene glycol with ascorbate – a randomized, parallel group, phase 2, colonoscopist-blinded trial 2019 ·BMC Gastroenterology ·Lucy Clayton, Bola Tayo, Marc Halphen, (unknown)	7
10	A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment 2019 ·The Journal of Clinical Pharmacology ·Lesley Taylor, Julie C. Crockett, Bola Tayo, Gilmour Morrison	83
11	A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects breakdown → 2018 ·CNS Drugs ·Lesley Taylor, Barry E. Gidal, Graham Blakey, Bola Tayo, Gilmour Morrison	341
12	Pharmacodynamic and Clinical Evaluation of Low-Volume Polyethylene Glycol (PEG)-Based Bowel Cleansing Solutions (NER1006) Using Split Dosing in Healthy and Screening Colonoscopy Subjects 2014 ·The American Journal of Gastroenterology ·Marc Halphen, Bola Tayo, (unknown), Lucy Clayton, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact